Authors/Disclosures
|
Rik R. Vandenberghe, MD, PhD
|
The institution of Dr. Vandenberghe has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. The institution of Dr. Vandenberghe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Vandenberghe has received research support from Stichting Alzheimer Onderzoek. The institution of Dr. Vandenberghe has received research support from KU Leuven Internal Funds. |
|
|
No disclosure on file |
|
Adrian Ivanoiu, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Eric Salmon, MD
(Pfizer Belgium)
|
No disclosure on file |
|
|
No disclosure on file |
|
Gunhild Waldemar, MD, DMSc
(Rigshospitalet, Dept. of Neurology)
|
No disclosure on file |
|
Steen Gregers G. Hasselbalch, MD
(Rigshospitalet)
|
No disclosure on file |
|
|
No disclosure on file |
|
Allan Andersen, MD, MSci
(Gloslrup University Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |